Searchable abstracts of presentations at key conferences in endocrinology

ea0049ep1034 | Pituitary - Clinical | ECE2017

Pregnancy outcome in women with prolactinomas exposed to dopamine agonists at early stages of gestation

Vorotnikova Svetlana , Skuridina Darya , Dzeranova Larisa , Pigarova Ekaterina , Belaya Zhanna

Introduction: Medical therapy with dopamine agonists is the best treatment for prolactinomas of any size or invasiveness and restores ovulatory cycles in 80–90% of patients. Cabergoline currently suggested nearly exclusively rather than other dopamine agonists due to its excellent tolerability and long half-life. That is why the question of safety using of this drug during pregnancy and embryo-fetal development is actual.Aim: The aim of the study is...